Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients

Michaela Döring, Dr. MD, Karin Melanie Cabanillas Stanchi, MSc, Manon Queudeville, Dr. MD, Ulrike Hartmann, Dr., Michael Ost, Dr. MD, Marie-Sarah Koch, Dr. MD, Carmen Malaval, Dr. MD, Markus Mezger, Dr. MD Dr. rer. nat., Sarah Schober, Dr. MD, Simone Weber, Dr. MD, Veit Lange, Dr. MD, Rupert Handgretinger, MD, Martin Ebinger, MD

Blood (2017) 130 (Supplement 1): 3228.

https://doi.org/10.1182/blood.V130.Suppl_1.3228.3228

Published: 2017

Journal Articles

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Christian M. Seitz, MD, Patrick Schlegel, MD, Jana Hau, Ann-Christin Krahl, Sarah Schroeder, Giulia Bender, Selina Reiter, Sabine Schleicher, PhD, Karin Schilbach, PhD, Martin Ebinger, MD, Philipp Knopf, MSc, Manfred Kneilling, MD, Bernd J. Pichler, PhD, Joerg Mittelstaet, PhD, Dominik Lock, MSc, Andrew Kaiser, PhD, Peter J. Lang, MD, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 1912.

https://doi.org/10.1182/blood.V130.Suppl_1.1912.1912

Published: 2017

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Bioluminescence in Vivo Imaging Improves the Model of Individual Patients' AML Cells Growing in Mice for Sensitive and Reliable Preclinical Treatment Trials on Various Genetic Subgroups

Irmela Jeremias, MD, Binje Vick, Dr., Maya Rothenberg, Nadine Sandhöfer, MSc, Michela Carlet, PhD, Christina Krupka, Andreas Trumpp, PhD, Selim Corbacioglu, MD, Martin Ebinger, MD, Maya Caroline Andre, MD, Wolfgang Hiddemann, MD, Stephanie Schneider, PhD, Marion Subklewe, MD, Klaus H Metzeler, MD, Karsten Spiekermann, MD

Blood (2014) 124 (21): 2323.

https://doi.org/10.1182/blood.V124.21.2323.2323

Published: 2014

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

EVI-1 Mediates Apoptosis Resistance Via CD261 Induction and Enhances Leukemogenic Potential in Human Acute Lymphoblastic Leukemia

Martina Konantz, PhD, Maya Caroline Andre, MD, Martin Ebinger, MD, Matthias Grauer, Hui Wang, Sarah Grzywna, Helmut R. Salih, MD, Rupert Handgretinger, MD, Olga S. Kustikova, PhD, Christopher Baum, MD, Lothar Kanz, MD, Klaus Schulze-Osthoff, PhD, Leticia Quintanilla-Martinez, MD, Frank Essmann, PhD, Claudia Lengerke, MD

Blood (2011) 118 (21): 1356.

https://doi.org/10.1182/blood.V118.21.1356.1356

Published: 2011

Journal Articles

Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers

Blood (2011) 118 (21): 1931.

https://doi.org/10.1182/blood.V118.21.1931.1931

Published: 2011

Journal Articles

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3076.

https://doi.org/10.1182/blood.V110.11.3076.3076

Published: 2007

Journal Articles

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3019.

https://doi.org/10.1182/blood.V110.11.3019.3019

Published: 2007

NARROW

Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients

Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Bioluminescence in Vivo Imaging Improves the Model of Individual Patients' AML Cells Growing in Mice for Sensitive and Reliable Preclinical Treatment Trials on Various Genetic Subgroups

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

EVI-1 Mediates Apoptosis Resistance Via CD261 Induction and Enhances Leukemogenic Potential in Human Acute Lymphoblastic Leukemia

Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only